BBC

Fund Description
Virtus LifeSci Biotech Clinical Trials ETF is an exchange-traded fund incorporated in the USA. The Fund seeks investment results that correspond to the performance of the LifeSci Biotechnology Clinical Trials Index. Clinical Trials stage companies are typically younger, smaller companies which do not have a drug approved, but instead focus on testing their experimental drugs.
Fund Profile
Fund Name Virtus LifeSci Biotech Clinical Trials ETF
Fund Exchange Ticker BBC
Fund Sponsor Bioshares
Fund ISIN US26923G3011
Net Expense Ratio 0.79 %
Fund Inception Date 17 December 2014
Fund Legal Structure ETF (Open end fund)
Exchange NYSE Arca
Listing Country Code US
Fund Investment Objective
ETF Type Specific US Equities - Industry Sector
Asset Class Equities (Stocks)
Index Linked Passive
Index Name LifeSci Biotechnology Clinical Trials Index
Index Provider LifeSci Index Partners
Currency Hedged No
Inverse / Leveraged Not Applicable
Developed / Emerging Developed Market Funds
Market Capitalization Range Broad Market / Multi-Cap
Growth Value Core / Blend
Continent North America
Key Statistics
Return As of Date 18 January 2019
Asset Under Management 27.95 Million (USD)
1 Month Total Return 6.33 %
Year To Date Return 9.00 %
1 Year Total Return -17.66 %
3 Year Annualized Total Return 8.54 %
NAV 25.4121
Share Outstanding 1,100,000
Top 10 Holdings (18 January 2019)
Constituent Name Constituent Ticker Constituent Type Weighting
BNY MELLON CASH RESERVE USD MMKT 0.0253
INSMED INC INSM EQUI 0.0174
EPIZYME INC EPZM EQUI 0.0166
MIRATI THERAPEUTICS INC MRTX EQUI 0.016
AGENUS INC AGEN EQUI 0.0154
SAGE THERAPEUTICS INC SAGE EQUI 0.0137
FIBROGEN INC FGEN EQUI 0.0133
NIGHTSTAR THERAPEUTICS PLC NITE EQUI 0.013
BLUEBIRD BIO INC BLUE EQUI 0.0127
CHEMOCENTRYX INC CCXI EQUI 0.0126